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ABSTRACT
Mitochondrial dynamics is a highly dysregulated process in cancer. Apoptosis and mitochondrial fission
are two concurrent events wherein increased mitochondrial fragmentation serves as a hallmark of
apoptosis. We have shown earlier that miR-195 exerts pro-apoptotic effects in breast cancer cells.
Herein, we have demonstrated miR-195 as a modulator of mitochondrial dynamics and function.
Imaging experiments upon miR-195 treatment have shown that mitochondria undergo extensive fission.
We validated mitofusin2 as a potential target of miR-195. This may provide a molecular explanation for
the respiratory defects induced by miR-195 over-expression in breast cancer cells. Active, but not total,
mitochondrial mass, was reduced with increasing levels of miR-195. We have further shown that miR-195
enhances mitochondrial SOD-2 expression but does not affect PINK1 levels in breast cancer cells.
Collectively, we have revealed that miR-195 is a modulator of mitochondrial dynamics by targeting
MFN2 thereby impairing mitochondrial function. Concomitantly, it enhances the scavenger of reactive
oxygen species (SOD-2) to maintain moderate levels of oxidative stress. Our findings suggest
a therapeutic potential of miR-195 in both ER-positive as well as ER-negative breast cancer cells.
ARTICLE HISTORY
Received 11 January 2019
Revised 19 March 2019
Accepted 25 March 2019
KEYWORDS
MiR-195; Mitofusin-2;
mitochondrial dysfunction;
breast cancer cells
Introduction
Breast cancer is one of the leading causes of death in
women worldwide. Treatment of breast cancer includes
radiation, surgery and chemotherapy. The majority of
breast tumours are hormone-dependent, and they account
for about 70% of breast cancers. About 80% of breast
cancers are ‘ER-positive’, i.e. the cancer cells grow in
response to the hormone estrogen [1]. About 65% of
these are also
‘PR-positive’ (Progesterone receptor).Tumours that are ER/
PR-positive are much more likely to respond to hormone
therapy than tumours that are ER/PR-negative.Triple nega-
tive breast cancer (TNBC) lacks all three receptors i.e.ER,
PR, and Her2. The Cancer therapy that targets these recep-
tors does not work well with TNBC tumour [2]. The devel-
opment of drug resistance to chemotherapy is one of the
major hurdles in treatment of breast cancer [3]. The exist-
ing therapeutic approaches are not sufficient to root-out
breast cancer. Consequently, development of novel drugs
that target tumours irrespective of their hormone receptor
status has a potential to strengthen the fight against breast
cancer.
A growing number of studies have shown that microRNAs
play key roles in the regulation of several cellular processes,whilst
microRNA expression profiling has been associated with tumour
development, progression and response to therapy [4,5].
MiRNAs are 20–25 nucleotide long sequences of non-coding
RNA that regulate gene expression post-transcriptionally.
MiRNAs mimics and antagomiR have been widely used to nor-
malize miRNA expression and hence gene expression networks
in disease conditions [6]. The ability of miRNA to restore gene
expression to physiologically normal level renders microRNA-
based strategies a potential therapeutic approach.
In several studies, hsa-miR-195 has been reported to be
differentially expressed in normal and breast cancer tissues
[7–10]. A decrease in hsa-miR-195 expression in cancer tissue
is due to increased methylation on the CpG Island of the miR-
195 promoter [11,12]. Further, increased circulatory level of
hsa-miR-195 in breast cancer patients and decline in circulatory
miR-195 post-operation make hsa-miR-195 a potential biomar-
ker for breast cancer [13–15]. In previous studies, we have
unveiled a pro-apoptotic role of miR-195 in breast cancer and
we have demonstrated that miR-195 downregulates Bcl2 by
direct binding to its 3ʹUTR Sequence [16]. In another study,
we have further shown the anti-proliferative, non-invasive and
anti-metastatic role of hsa-miR-195 in breast cancer cells [17].
These findings suggest hsa-miR-195 has strong anticancer prop-
erties with a promising therapeutic potential in breast cancer.
Besides its pro-apoptotic role, hsa-miR-195 has also been shown
to depolarize the mitochondrial inner membrane and to
increase the calcium concentration in mitochondria [17].
Despite all previous studies, it remains unclear how miR-195
affects mitochondrial function. During our in-silico analysis we
observed that mitofusin-2(MFN2) a predicted target of hsa-miR
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-195. Further analyzing our illumina microarray data, we found
a differential expression of MFN2 upon over-expression of miR-
195 in breast cancer cells. Herein, we have validated mitofusin-2
as a direct target of miR-195 in breast cancer cell lines. Over-
expression of miR-195 in breast cancer cell induces mitochon-
drial fragmentation and diminishes the ability for mitochondria
to consume oxygen. The observed functional impairment of
mitochondria induced by miR-195 is independent of the ER
(Estrogen receptor) status of cells.
Results
MiR-195 down regulates MFN2 in breast cancer cell lines
We have previously shown that miR-195 affects mitochon-
drial function by means of depolarization of the inner mem-
brane and disturbing calcium homeostasis within the
organelle [17]. However, the exact mechanism by which
these processes are controlled was not investigated. In-silico
analysis using target scan revealed a miR-195 binding site in
the 3ʹUTR of MFN2 (Figure 1(A)). Mitofusin-2 is a crucial
protein known to play a role in controlling mitochondrial
dynamics and maintenance of mitochondrial calcium home-
ostasis. The miR-195 was upregulated using pSilencermiR-195
(miR) cloned vector whereas downregulated using antimiR-
195 (AM)(Figure 1(B)). As shown in Figure 1(C), western blot
analysis revealed significant downregulation (p-value<0.0005)
of MFN2 upon over-expression of miR-195 in MCF-7 and
MDA-MB-231 cells. While, MFN2 levels were significantly
increased (p-value<0.0005) when miR-195 expression was
reduced in MCF-7 and MDA-MB-231 cell lines. The dual
luciferase assay was performed to check direct binding of
miR-195 to 3ʹUTR sequence of MFN2. The luciferase activity
was reduced by 0.4 fold (p-value<0.05) upon up-regulation of
miR-195 in MDA-MB-231 cells whereas 0.16 fold decrease in
luciferase activity was observed in MCF-7 cells (Figure D),
The luciferase activity was restored back to normal when the
miR-195 binding site was deleted from the luciferase assay
plasmid (pSichek) further confirming direct binding of miR-
195 to the 3ʹUTR sequence of MFN2.
MiR-195 affects mitochondrial morphology
Mitochondrial morphology is a critical factor that determines
its activity. MFN2 has been shown to affect mitochondrial
dynamics by promoting fusion events and hence the mito-
chondrial morphology. Mitotracker Red CMXRos has been
used to check morphology of the organelle. We observed
increase fragmentation of mitochondria when we over-
expressed miR-195 in MCF-7 and MDA-MB-231 cell lines
(Figure 2(A,B)). The highly networked tubular mitochondria
Figure 1. MiR-195 downregulates mitofusin-2 (mfn-2) by directly binding to its 3ʹUTR sequence.
(a) Predicted binding sites of miR-195 on 3ʹUTR sequence of MFN2 m-RNA (b) MiR-195 over-expressed using p195 plasmid construct (miR-195) and knockdown using
antimiR-195 (AM) in MCF-7 and MDAMB231 cells (c1)MiR-195 over-expression depleted MFN2 protein levels while knockdown of miR-195 enhances MFN2 protein
levels in MCF-7 and MDA-MB-231cells (c2)Mean fold change in MFN2 level ±SE for n = 3 was plotted (d) Over-expression of miR-195 diminishes relative
luminescence in breast cancer cells, Representative plot of luciferase assay, mean fold change ±SE for n = 3 was plotted,*: p< 0.05, ***: p< 0.001. (pSil, miR-195,
NC,AM represents treatment of control plasmid, miR-195 plasmid, negative control and antimiR-195, respectively)
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in control (pSilencer treated) cells tend to become rounded,
small an fragmented in shape upon over-expression of miR-
195 in both cell lines, the mitochondrial shape was restored
back to elongated tubular even upon up-regulation of miR-
195 when cells were treated with MFN2 that does not contain
the 3ʹUTR sequence (pMfn2). This confirms that the 3ʹUTR
sequence of MFN2 is requisite for miR-195 to enhance mito-
chondrial fission. The mitochondrial division inhibitor Mdivi-
1 was used as a positive control of fusion events and hence
tubular shape of organelle was observed upon treatment of
Mdivi-1 in both breast cancer cell lines (Figure 2(A,B)).The
mean branch length of mitochondria was reduced by 0.4 fold
upon up-regulation of miR-195 in MCF-7 (p-value<0.05) and
MDAMB-231 (p-value<0.01) cells, respectively (Figure 2(C,
D)). The mean branch length was restored back like control
(pSilencer treated) when cells were treated with pMfn2 along
with miR-195. Mdivi-1 treatment also enhanced mitochon-
drial branch length in comparison to miR-195 treatment in
both breast cancer cells (Figure 2(C,D)).
MiR-195 promotes mitochondrial fission by blocking
fusion events
Mitochondrial morphology is critical for its function and it is
regulated by mitochondrial dynamics. Apart from mitofusins
there are other proteins whose levels change markedly during
mitochondrial fusion and fission events. Here we found that
up-regulation of miR-195 affects the levels of both DRP1
(dynamin-related protein) and OPA1. Specifically, in MCF-7
cells, DRP1 increases 1.9-fold (Figure 3(A) first panel) whilst
OPA1 decreases 0.32-fold (Figure 3(D) first panel). In
MDAMB-231 cells 1.32-fold increase in DRP1 level was
observed (Figure 3(A) second panel) whereas a 0.36-fold
decrease in the OPA1 level (Figure 3(D) second panel)
Conversely, knockdown of miR-195 has different effects.
In MCF-7 cells DRP1 decreases 0.3-fold (p-value<0.05)
(Figure 3(B) first panel) and OPA1 increases 1.9-fold
(Figure 3(E) first panel). In MDAMB-231 cells DRP1
decreases 0.2-fold (Figure 3(B) second panel) whilst OPA1
increases 1.60-fold (Figure 3(E) second panel) The antimiR-
195 treatment in both cell lines shows exactly opposite effects
to that of miR-195. The enhanced DRP1 expression and
reduced OPA1 protein level is a sign of miR-195 induced
increase in mitochondrial fission events in breast cancer cell
lines.
MiR-195 diminishes active mitochondrial mass but does
not promote degradation of mitochondria through
mitophagy
Mitophagy and mitochondrial dynamics are two inter-
connected processes needed to maintain fully functional
mitochondria by targeting defective and damaged mitochon-
dria to a dedicated degradation process. Mitophagy is not the
only process by which a healthy pool of mitochondria is
maintained since damaged mitochondria can also undergo
Figure 2. Mitofusin-2 down-regulation by miR-195 changes mitochondrial morphology and promote mitochondrial fission.
Mitochondria become rounded, small and fragmented upon up-regulation of miR-195 and gets tubular in shape upon treatment of MFN2 along with miR-195 and
Mdivi-1 treatment in (a) MCF-7 cells and (b) MDAMB-231 cells. Bar: 100 µm. The mean branch length of mitochondria reduces upon miR-195 treatment and restored
back upon treatment of MFN2 along with miR-195 and Mdivi-1 treatment in (c)MCF-7 and (d)MDAMB-231, mean branch length ±SE for n = 3 was plotted, *: p< 0.05,
***: p< 0.001.
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a repair pathway or they can fuse with completely healthy
mitochondria and compensate the damage. As fusion events
are blocked by miR-195 through the targeting of MFN2,
therefore, fusion of damaged mitochondria with healthy
ones is no longer an option for mitochondria to overcome
the damaging oxidative stress. We have therefore checked for
mitochondrial mass and mitophagy. The VDAC1 and
mtHSP70 proteins are used as mitochondrial mass markers
whilst PINK1 is used as a mitophagy marker. Upon over-
expression of miR-195 or knockdown of miR-195, none of
these markers (Figure 4(A) for PINK1, 4B for VDAC1, 4C
mtHSP70 protein) have shown any significant difference
compared to the vehicle control in MCF-7 and MDA-MB
-231 cell lines. These observations clearly suggest that miR-
195 does not promote degradation through mitophagy of
damaged mitochondria and hence total mitochondria mass
does not change. We further probed for the functionally
active mitochondria pool using Mitotracker Red CMXRos
(which is highly dependent on a functional mitochondrial
transmembrane potential). We observed a decrease of active
mass of mitochondria upon miR-195 treatment in MCF-7
and MDA-MB-231 cell lines. On the other hand, the mass of
active mitochondria increased upon down-regulation of miR-
195 in both cell lines. CCCP treatment was used as a positive
control. Taken together, these observations suggest that miR-
195-mediated mitochondrial membrane depolarization is not
severe enough to induce mitophagy, but it is sufficient to
diminish mitochondrial activity and hence the pool of active
mitochondria.
MiR-195 induces a defect in mitochondrial respiration
To further validate the effect of miR-195 on aerobic respiration,
the oxygen consumption rates of mitochondria (OCR) measured
directly with a SeaHorse-XF24 flux analyser. The over-expression
of miR-195 shows a respiratory defect as OCR is reduced, whilst
down-regulation of mir-195 resulted in an increase in OCR in
both the MCF-7 and the MDA-MB-231 cell lines. The OCR was
used to further calculate other respiratory parameters such as basal
respiration, maximal respiration, ATP production and spare
respiratory capacity of mitochondria. miR-195 appears to attenu-
ate basal respiration by 0.3 fold in MCF-7 and 0.35 fold in MDA-
MB-231 cell lines whereas antimiR-195 treatment increases basal
respiration by 1.24 fold and 1.27 fold in MCF-7 and MDA-MB
Figure 3. MiR-195 affects mitochondrial dynamics by blocking fusion.
(a) Dynamin-related protein (DRP1) gets upregulated upon over-expression of miR-195 in MCF-7 cells (right panel) and MDA-MB-231 cells (left panel) (b) Knockdown
of miR-195 using antimiR-195 (AM) reduces DRP1 protein levels in MCF-7 cells (right panel) and MDA-MB-231 cells (left panel) (d) Mitochondrial inner membrane
GTPase (OPA1) gets down-regulated upon over-expression of miR-195 in MCF-7 cells (right panel) and MDA-MB-231 cells (left panel) (e) Depletion of miR-195 using
AM enhances OPA1 levels in MCF-7 cells (right panel) and MDA-MB-231 cells (left panel) (c, f) Mean fold change ±SE for n = 3 was plotted, *: p< 0.05, ***: p< 0.001.
(pSil, miR, NC, AM represents treatment of control plasmid, miR-195 plasmid, negative control and antimiR-195, respectively)
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-231 cell lines, respectively (Figure 5(C)), Themaximal respiration
also decreases by 0.35 fold and 0.3 fold in MCF-7 and MDA-MB
-231 cell lines respectively, on contrary down-regulation of miR-
195 enhancesmaximal respiration by 1.27 fold inMCF-7 and 1.47
fold inMDA-MB-231 cell lines (Figure 5(D)). As shown in Figure
5(E), miR-195 over-expression diminishes spare respiratory capa-
city by 0.33 fold and 0.51 fold in MCF-7 and MDA-MB-231 cell
line respectively, on the other hand antimiR-195 increases spare
capacity of mitochondria by 3.75 fold in MCF-7 and 2.16 fold in
MDA-MB-231 cell lines. The OCR derived ATP production also
decreases by 0.42 fold and 0.22 fold inMCF-7 andMDA-MB-231
cell lines, respectively, upon up-regulation of miR-195, conversely
reduction in miR-195 level by antimiR-195 augments ATP pro-
duction by 1.3 fold in MCF-7 and 3.72 fold in MDA-MB-231 cell
line (Figure 5(F)).
Oxidative stress is augmented by miR-195
The mitochondria are a prime source of energy production in
cells, wherein, they utilizes the proton gradient across the mem-
brane to generate ATP and convert molecular oxygen into water
as a byproduct. The process of oxidative phosphorylation and
electron transfer constantly takes place in inner mitochondrial
membrane of metabolically active cells. The activity and proper
assembly of electron transport chain complexes plays a central
role in the electron flow and generation of the proton gradient
across the membrane. Any defect in the ETC components leads
to leakage of electrons to the mitochondrial matrix and that in
turn converts molecular oxygen to superoxide, a damaging ROS.
To check the effect of miR-195 on oxidative stress, we have
probed for mitochondrial superoxide using MitoSox Red,
a fluorescent probe that is rapidly oxidized by superoxides in
mitochondria and produces red fluorescence. The over-
expression of miR-195 enhanced superoxide levels 1.2- fold in
MCF-7 cells and 1.13-fold in MDA-MB-231 cells (Figure 6(C)).
This increase in mitochondrial ROS suggests the involvement of
ETC in the effect exerted by miR-195 on mitochondrial
dynamics. To further examine the effects on ROS, we checked
the expression of MnSOD2 as it is the key scavenger of super-
oxide in the matrix of mitochondria. Interestingly, the level of
MnSOD2 increased 1.2-fold (p-value<0.05) in MCF-7 cells and
2.0 fold (p-value<0.01) in MDA-MB-231 upon over-expression
Figure 4. MiR-195 diminishes Active mitochondrial mass but not the total mass of mitochondria.
(a) Mitophagy marker PINK1 levels were not significantly changed with differential expression of miR-195 in MCF-7 (right panel) and MDA-MB-231 cells (left panel).
The alteration in miR-195 level does not affect the protein level of (b) VDAC1 (mitophagy and mitochondrial mass marker) as well (c) mt-hsp70 (mitochondrial mass
marker) in both breast cancer cell lines. Mean fold change ±SE for n = 3 was plotted (d) Active mass of mitochondria was reduced upon miR-195 over-expression
whereas active mass got resumed to normal levels with depletion of miR-195 in MCF-7 and MDA-MB-231 cells, the positive control CCCP treated cells have shown
lesser mitochondrial active mass, plot is representation of fold change in mean fluorescence intensity ±SE, *: p< 0.05, ***: p< 0.001. (pSil, miR, NC, AM represents
treatment of control plasmid, miR-195 plasmid, negative control and antimiR-195, respectively)
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of miR-195 (Figure 6(A,B)). Conversely, the MnSOD2 level
decreased 0.3-fold (p-value<0.05) in both MCF-7 and MDA-
MB-231 cells when miR-195 was down-regulated (Figure 6(A,
B)). This additional evidence supports the role of miR-195 in
maintaining the mitochondrial superoxide concentration at
non-damaging levels by up-regulating its main scavenger pro-
tein (MnSOD2) and hence bypassing the mitophagy process.
Apoptosis induced by MiR-195 is independent of MFN-2
mediated mitochondrial dysfunction
Mitochondrial superoxide generation is often associated with
increased cell death [18]. To further investigate the effect of miR-
195 mediated mitochondrial dysfunction on apoptosis, an
Annexin-V apoptosis assay was performed. The over-expression
ofmiR-195 enhanced apoptosis (Annexin-V positive cells) by 1.33
fold (p-value<0.05) in MCF-7 cells (Figure 7(B)) whereas in
MDAMB-231 cells an insignificant increase in apoptosis was
observed (supplementary Figure 1B). There was also a significant
increase in apoptosis (p-value<0.05) when both the cell lines were
treated with pMfn2 (construct without UTR) along with miR-195
as compared to their respective controls (Figure 7(B), supp. Figure
1B). Our findings suggest that the pro-apoptotic effects exerted by
miR-195 did not get reversed upon restoring MFN2 levels in both
breast cancer cell lines. Hence, the induction of apoptosis by miR-
195 is independent ofMFN2mediatedmitochondrial dysfunction.
Furthermore, the blocking of mitochondrial fission by chemical
inhibitor Mdivi-1 also caused significantly increased apoptosis
(p-value<0.01) in both cell lines (Figure 7(B),supp. Figure 1B).
Taken together these findings indicate that any disturbance in
mitochondrial dynamics and hence mitochondrial quality control
leads to enhanced apoptosis.
Discussion
Healthy mitochondria play a critical role in the determina-
tion of cell fate and the maintenance of cellular homeostasis.
Mitochondrial dysfunction is a pathological hallmark for
different diseases and stress-induced mitochondrial dysfunc-
tion is known to activate the intrinsic pathway of apoptosis
[19–22]. The dynamic nature of mitochondria ensures their
quality, whilst unhealthy mitochondria with irreparable
damage undergo a specific degradation process called mito-
phagy [23–27]. A healthy pool of mitochondria is
Figure 5. MiR-195 reduces oxygen consumption rate via MFN2 down-regulation.
Elevated levels of miR-195 reduces OCR whereas declining miR-195 levels augments OCR in (a) MCF-7 cells and (b) MDA-MB-231 cells, normalized OCR per min per
microgram of protein ±SE from n = 3 was plotted. The respiratory parameters such as (c) Basal respiration, (d) Maximal respiration, (e) Spare respiratory capacity of
mitochondria and (f) ATP production was derived from OCR and mean fold change was plotted ±SE, *: p< 0.05, ***: p< 0.001. (pSil, miR, NC, AM represents treatment
of control plasmid, miR-195 plasmid, negative control and antimiR-195, respectively)
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maintained by a series of fusion-fission events. Mitofusin1
and Mitofusin2 facilitate fusion of the outer mitochondrial
membrane [28–30], while the inner mitochondrial mem-
brane gets fused by the inner membrane GTPase protein
OPA1 [31–33]. Mitochondrial fission is triggered upon loca-
lization of the DRP1 and FIS1 proteins on the scissor site
[34–37]. In conclusion, mitochondrial dynamics and mito-
chondrial morphology are highly linked processes that play
Figure 6. Moderate levels of mitochondrial oxidative stress are maintained by miR-195.
(a) Mitochondrial superoxide scavenger (mn-SOD2) elevates with miR-195 up-regulation whereas mn-SOD2 levels declined upon depletion of miR-195 in MCF-7 and
MDA-MB-231 cells. (b) Mean fold change ±SE for n = 3 was plotted. (c) Mitochondrial superoxide level was augmented mildly upon over-expression of miR-195 in
both breast cancer cells, relative fold change in mean fluorescence ±SE was plotted from n = 3 for MDA-MB-231 and n = 4 for MCF-7, *: p< 0.05, ***: p< 0.001. (pSil,
miR, NC,AM represents treatment of control plasmid miR-195 plasmid, negative control and antimiR-195, respectively)
Figure 7. Apoptosis induced by MiR-195 is independent of MFN-2 mediated mitochondrial dysfunction.
(a) Histogram of Annexin V-PE and 7-AAD binding upon treatment of miR-195, MFN2 along with miR-195, MFN2 and Mdivi-1 in MCF-7 cells. (b) Plots are a
representation of relative percentage apoptosis ±SE from n = 3 in MCF-7, *: p< 0.05, ***: p< 0.001.
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a major role in mitochondrial quality control to maintain
cellular homeostasis.
Previously we demonstrated that hsa-miR-195 targets Bcl-
2, it causes mitochondrial dysfunction, it induces apoptosis
and augments the effect of etoposide in breast cancer cells.
We further demonstrated that miR-195 also targets genes
involved in de novo lipogenesis, it inhibits cell proliferation,
migration, and invasion by targeting FASN, HMGCR,
ACACA and CYP27B1 thereby potentially opening new ave-
nues for the treatment of breast cancer. However, the under-
lying mechanism by which miR-195 causes mitochondrial
dysfunction remains unexplored. MicroRNAs that affect
mitochondrial function have been explored and studied in
various disease contexts [38–40]. Wherein miR-668 has been
shown to affect mitochondrial dynamics during ischemic
acute kidney injury [41]. Similarly, Juan Ji et.al. has also
reported that miR-141-3p targets PTEN to induce mitochon-
drial dysfunction in high fat diet induced obesity [42].
Herein, we first checked whether miR-195 can regulate
mitochondrial shape and function. Our current findings
revealed that miR-195 modulates mitochondrial shape and
enhances fragmentation of mitochondria in breast cancer
cells (Figure 2). We also identified MFN2 to be a direct target
of miR-195 in apoptotic breast cancer cell lines. The miR-195
has been previously reported to target MFN2 in Alzheimer's
disease mice [43] but the correlation of miR-195 and MFN2
and its implication on mitochondrial dynamics has not been
explored before in breast cancer. The expression of MFN2 has
been shown by other groups to be implicated in various
cancers [44]. The over-expression of MFN2 has been observed
to enhance tumorigenesis while inhibition of MFN2 has been
revealed to exert anti-cancer effects in human gastric cancer
[45]. Further, MFN2 has been shown to affect mitochondrial
dynamics by promoting fusion events. In an independent
study, Leboucher and colleagues reported that the phosphor-
ylation and proteosomal degradation of MFN2 under stress
condition facilitates mitochondrial fission and apoptosis [46].
On the contrary, Li Ma et al. have shown that MFN2 induces
apoptosis via PI3K/Akt signaling in breast cancer cells [47]. In
addition to this, Xu K et al. further reported that MFN2
suppresses cancer progression by inhibition of the
mTORC2/Akt signalling pathway [48]. Furthermore, 17β-
estradiol has been observed to enhance proliferation and
migration of MCF-7 cells by down-regulating mfn2 [49].
Therefore, the role of MFN2 in apoptotic pathways is
contextual.
We further demonstrated that miR-195 reduces the effi-
ciency of mitochondria to consume oxygen. The observed
differential levels of OPA1 and DRP1 upon alteration of
miR-195 expression further suggested an indirect involvement
of both proteins in modulation of mitochondrial dynamics by
miR-195. Next, we were curious to know the fate of fragmen-
ted mitochondria in apoptotic breast cancer cells upon up-
regulation of miR-195. Mitochondrial fission and increased
oxidative stress is often known to decrease mitochondrial
mass by committing damaged mitochondria to mitophagy.
However, to our surprise, we did not observe any change in
mitochondrial mass and hence no mitophagy but there was
a decrease in the mass of active mitochondria. Taken together,
these observations suggest that miR-195 affects mitochondrial
functions and enhances oxidative stress but the stress is not
sufficient to trigger mitophagy (Figure 8). It seems that miR-
195 induces moderate oxidative stress to compromise mito-
chondrial activity and that is the reason behind a reduced
mass of active mitochondria (Figure 8).
Further, to check how the moderate level of stress is being
maintained by miR-195, we analyzed the mitochondrial
MnSOD2 and observed significant upregulation of superoxide
scavenging in mitochondria under the influence of miR-195.
This illustrates a very subtle effect of miR-195 that enhances
oxidative stress on the one hand by affecting mitochondrial
dynamics, whilst it does not allow excess ROS accumulation
by enhancing the level of the scavenger (MnSOD2) (Figure 8).
Recently it has been shown that the mitochondrial fission
machinery plays a critical role in mitochondrial fragmentation
during apoptosis [50]. Herein, we have measured apoptotic
cell death induced by miR-195. The restoration of MFN2 level
with deleted 3ʹUTR sequence (pMfn2) did not decrease miR-
195 induced apoptosis thereby suggesting that the pro-
apoptotic role of miR-195 is MFN2-independent in breast
cancer cells. The induction of apoptosis by down-regulation
BCL2 [16] and mitochondrial fragmentation via reduction of
MFN2 levels by miR-195 seem to be two parallel events.
Wherein, mitochondrial fragmentation by miR-195 during
apoptosis is attained by MFN-2 down-regulation.
Our results revealed miR-195 mediated potential respira-
tory defects in MCF-7 and MDA-MB-231 cell lines that char-
acterize miR-195 as a modulator of mitochondrial respiration.
The current study gives detailed mechanistic insight into the
mitochondrial functional impairment by miR-195 in apopto-
tic breast cancer cell lines. The results presented here expand
our previous finding that miR-195 mediates differential
expression of components of the mitochondrial electron
transfer chain in breast cancer cell lines [17]. The present
study provides a much needed framework to gain further
insight into the role of miR-195 as a putative potential ther-
apeutic molecule not just in cancer but various metabolic as
well as neurodegenerative diseases where mitochondrial func-
tion is compromised.
Materials and methods
Cell culture
Human breast adeno carcinoma cell lines MCF-7 and MDA-
MB-231 were procured from the National Centre for Cell
Sciences (NCCS), Pune, India and cultured using DMEM
containing 10% (v/v) fetal calf serum, 100 Units/ml penicillin,
100 μg/ml streptomycin, 0.25 μg/ml amphotericin at 37°C in
a humidified atmosphere at 5% CO2.
MiR-195 over-expression and knockdown
Over-expression of miR-195 was achieved using p195 (237 bp
sequence containing premiR-195 cloned in psilencer 4.1 vector
purchased from Ambion, Austin, TX, USA) [16] and pSilencer
4.1 empty vector was used as a control. ThemiR-195 knockdown
was done using AntimiR-195 oligos (AM17000) and AntimiR
RNA BIOLOGY 925
miRNA inhibitor negative control (AM17010). Both oligos were
purchased from Ambion, Austin, TX, USA. Lipofectamine 2000
and Lipofectamine LTX-Plus (Invitrogen, CA, USA) were used
for transfection according tomanufacturer’s protocol. Cells were
trypsinized and harvested 24 hours post-transfection. The
MFN2 plasmid without the 3ʹUTR sequence (pMfn2) was pur-
chased from addgene (plasmid number 28010) [51]. We are
working with miR-195-5p in this manuscript.
Mitochondrial morphology
The mitochondrial shape was visualized using the mitochon-
dria-specific probe mitotracker CMXRos [52]. CMXRos is
a fluorescent dye that is lipophilic and cationic in nature.
CMXRos binds to the negatively charged matrix side of the
mitochondrial inner membrane. Cells were stained with 200
nM CMXRos for 15 min at 37 ⁰C post miR-195 treatments in
a cell culture incubator. The MFN2 plasmid without the
3ʹUTR sequence (pMfn2) was purchased from addgene (plas-
mid number 28010) [51] and used for over expression of
MFN2 along with miR-195. The mitochondrial division inhi-
bitor Mdivi-1 was purchased from sigma (sigma, USA) and
used at 75 µM concentration for 2 h. Cells were fixed post
staining using 4% paraformaldehyde and visualized at 63X
magnification using a confocal fluorescence microscope
(Leica SP8, Germany) for mitochondrial shape and a Nikon
Ti-e microscope for quantification of mitochondrial length.
The images were processed and mitochondrial branch length
of nearly 150 cells was measured using Image-J software.
RNA isolation and TaqMan assay
The miRNA-195 overexpression and knockdown was analysed
using Taqman probes specific to miR-195. The taqMan miRNA
assay probes (RT000494 and TM000494) were purchased from
applied biosystems. The total RNA was isolated from MCF-7
and MDA-MB-231 cell lines 24 hours post transfections with
p195, antimiR-195 and their respective controls. The Trizol
reagent (Ambion by Invitrogen, CA, USA) was used as per
manufacturer’s instructions to isolate total RNA. The Integrity
of RNA samples were checked using a 1% agarose gel in TAE
buffer system. Quantification was done using a nanodrop and
absorbance measurements at 260 nm, 280 nm and 230 nm. Five
hundred nanograms of RNA of each sample was used to synthe-
size c-DNA using RevertAid H minus first strand cDNA synth-
esis kit as per manufacturer’s protocol for 18s r-RNA, whereas
miR195-specific cDNA was synthesized using the miR-195 spe-
cific primer (RT000494) and the TaqMan reverse transcription
kit (Applied Biosystems) as per manufacturer’s protocol. The
expression of matured miR-195 was estimated using TaqMan
miRNA assay probe (TM000494, Applied Biosystems), the 18s
r-RNA (Ref-4333760F, Applied Biosystems) was used to nor-
malize the miR-195 expression. Data analysis was done using
Pfaffl’s method [53].
Protein preparation and western blotting
Cells were lysed with RIPA lysis buffer (50 mM Tris–HCl, pH
7.4, 150 mM NaCl, 1% NP40, 0.25% Na-deoxycholate, 1 mM
Figure 8. Schematic diagram showing miR-195 mediated mitochondrial functional impairment via MFN2.
MiR-195 affects mitochondrial dynamics by blocking MFN2 mediated mitochondrial fusion. The fragmented mitochondria as a result of miR-195 over-expression are
metabolically less active with repairable oxidative stress.
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EDTA) containing protease inhibitors (1 μg/ml aprotinin,
1 μg/ml pepstatin, 1 μg/ml leupeptin, 1 mM PMSF,1 mM
sodium fluoride and 1 mM sodium orthovanadate) for 30 min
on ice. The lysates were centrifuged at 16,000 g for 30 min at 4°C
and the supernatant was collected. Protein concentration was
estimated by the BCA (Sigma, USA) method. Equal amount of
proteins (50–100 μg) were separated on 10%-12% sodium dode-
cyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE).
Separated protein was further transferred to PVDF membrane
(Mdi; Advanced Microdevices, India). The membrane was
blocked using 5% Bovine serum albumin (BSA) for 1 h at RT
and incubated with the respective antibodies in 1% BSA for 16
h at 4⁰C, the blot was washed three times using TBST, and then
further incubated with the suitable secondary antibody for 1 h at
room temperature. DRP1, OPA1 and MFN2 antibody were
purchased from Abcam (Cambridge, UK) and used at 1:1000
concentrations. VDAC1 antibody was purchased from cell sig-
nalling and used at 1:1000 concentrations. β-actin and GAPDH
were obtained from Sigma (Sigma, USA) and used at 1:5000
concentrations. β–actin and GAPDH were used as protein load-
ing controls to normalize the results. The secondary antibodies
were HRP-linked and used at 1:5000 concentration and blots
were developed using enhanced chemi-luminiscence (Pierce,
Amersham). Integrated density values were calculated using
the Image-J software.
Luciferase reporter assay
The 3′UTR of MFN2 gene was cloned in pSichek2 luciferase
vector backbone (Promega, Madison, WI, USA) and the dele-
tion mutant of miR-195 binding site in MFN2 3ʹUTR (dele-
tion in position 1784–1790) was created using quick change-II
site directed mutagenesis kit (Agilent technologies, USA). 100
ng of plasmid was used along with the miR-195 treatment in
a 12-well cell culture plate. Luciferase activity was measured
using the dual luciferase reporter assay system (Promega,
Madison, WI, USA) as per manufacturer’s protocol.
Oxygen consumption rate measurement
For metabolic flux measurement 60,000 to 80,000 cells were
seeded in each well of a XF-24 plate, whilst for the plate that
was used as a blank (A1, B4, C3, D6) no cells were seeded in the
wells. Transfection of miR-195, AntimiR-195 and their respec-
tive controls was done using Lipofectamine 2000 (Invitrogen,
CA, USA) reagent at 70% to 80% cell confluency. 24 hours post-
transfection the cells were washed with XF-24 assay media and
incubated in the same buffer for 1 h at 37 ⁰C in a CO2-free
environment. A pre-hydrated XF-24 cartridge was loaded with
inhibitor in their respective chambers. A cartridge with utility
plate was kept in XF-24 flux analyser machine and the program
was run. After the calibration step, the utility plate was replaced
with the cell culture plate and the metabolic flux of the cells was
measured. The protein estimation was done using the Bradford
method post-experiment to check the equal seeding density in
each well of XF-24 flux analyser. The data were normalized per
microgram of protein [54].
Mitochondrial mass measurement
Cells were seeded in 12-well plates and treatment was given once
the desired confluency was reached. 50 µM CCCP treatment for
2 h was given as a positive control of mitochondrial mass
reduction. Cells were washed post treatment and staining was
done using 200 nM mitotracker CMXRos for 15 min at 37 ⁰C.
Cells were washed using PBS and harvested. Cells were further
acquired using FACS (EasyCyte Guava Technologies).
Mitochondrial reactive oxygen species measurement
Mitochondrial superoxide was measured using MitosoxRed
staining [55]. The cells were seeded in 24 well plate and miR-
195 treatment was given at 70% cell confluency. 1 µM rotenone
was used as positive control to generate endogenous superoxide
radicals. Mitochondrial superoxide was stained using 5 µM
MitosoxRed for 20 min at 37 ⁰C. Cells were harvested using
0.5% trypsin and washed with PBS. The cells were acquired
using FACS (EasyCyte Guava Technologies).
Annexin assay
Apoptosis was assessed using Guava Nexin kit (Guava
Technologies) that contains annexin V-PE and 7-AAD. The
treatments of miR-195, MFN2 plasmid without 3ʹUTR
(pMfn2) and Mdivi-1 were given in a 12 well cell culture
plate. Cells were treated with 75 µM Mdivi-1 for 2 h before
staining. The staining of cells was done as per the manufac-
turer’s protocol and samples were acquired using FACS
(EasyCyte Guava Technologies and BD Accuri C6 Plus).
Statistical analysis
A two-tailed student t-Test was used for statistical analysis.
Mean of a minimum of two or a maximum of four indepen-
dent experiments ±SE is plotted. P-value less than 0.05, less
than 0.01 and less than 0.001 is represented by *, ** and ***,
respectively, on plots.
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